These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23621232)

  • 1. Lymph node ratio is more predictive than traditional lymph node stratification in lymph node positive invasive breast cancer.
    Bai LS; Chen C; Gong YP; Wei W; Tu Y; Yao F; Li JJ; Wang LJ; Sun SR
    Asian Pac J Cancer Prev; 2013; 14(2):753-7. PubMed ID: 23621232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic axillary lymph node ratio (LNR) is prognostically superior to pN staging in patients with breast cancer--results for 804 Chinese patients from a single institution.
    Xiao XS; Tang HL; Xie XH; Li LS; Kong YN; Wu MQ; Yang L; Gao J; Wei WD; Xie X
    Asian Pac J Cancer Prev; 2013; 14(9):5219-23. PubMed ID: 24175804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional prognostic value of lymph node ratio over pN staging in different breast cancer subtypes based on the results of 1,656 patients.
    Ataseven B; Kümmel S; Weikel W; Heitz F; Holtschmidt J; Lorenz-Salehi F; Kümmel A; Traut A; Blohmer J; Harter P; du Bois A
    Arch Gynecol Obstet; 2015 May; 291(5):1153-66. PubMed ID: 25367604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of metastatic axillary lymph node ratio in node-positive breast cancer treated by breast conserving surgery].
    Zheng Y; Chen Q; Liang Z; Jia M; Cao X
    Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):41-6. PubMed ID: 25877318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy.
    Wu SG; Chen Y; Sun JY; Li FY; Lin Q; Lin HX; He ZY
    Radiat Oncol; 2013 May; 8():119. PubMed ID: 23672513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging.
    Chen S; Liu Y; Huang L; Chen CM; Wu J; Shao ZM
    Ann Surg Oncol; 2014 Jan; 21(1):42-50. PubMed ID: 24013900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
    Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
    J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of axillary lymph node metastases in invasive lobular breast carcinoma.
    Deberti M; Goupille C; Arbion F; Vilde A; Body G; Ouldamer L
    J Gynecol Obstet Hum Reprod; 2023 Dec; 52(10):102665. PubMed ID: 37734568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with long-term follow-up.
    Danko ME; Bennett KM; Zhai J; Marks JR; Olson JA
    J Am Coll Surg; 2010 May; 210(5):797-805.e1, 805-7. PubMed ID: 20421053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society.
    Ahn SH; Kim HJ; Lee JW; Gong GY; Noh DY; Yang JH; Jung SS; Park HY
    Breast Cancer Res Treat; 2011 Nov; 130(2):507-15. PubMed ID: 21858659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node ratio: a new feature for defining risk category of node-positive breast cancer patients.
    Yang C; Liu F; Li S; Li W; Zhai L; Ren M; Li Y; Lang R; Fan Y; Zhang X; Fu L
    Int J Surg Pathol; 2012 Dec; 20(6):546-54. PubMed ID: 22736300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Value of the Number of Harvested Lymph Nodes and Cut-Off for Lymph Node Ratio in the Prognosis of Stage II and III Colorectal Cancer Patients.
    Li Destri G; Barchitta M; Pesce A; Latteri S; Bosco D; Di Cataldo A; Agodi A; Puleo S
    J Invest Surg; 2019 Jan; 32(1):1-7. PubMed ID: 28972442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy.
    Kim SI; Kim TH; Lee M; Kim HS; Chung HH; Lee TS; Jeon HW; Kim JW; Park NH; Song YS
    Yonsei Med J; 2021 Mar; 62(3):231-239. PubMed ID: 33635013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients.
    Singh D; Mandal A
    Breast Cancer Res Treat; 2020 Dec; 184(3):839-848. PubMed ID: 32852709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node ratio as an alternative to pN staging for predicting prognosis after neoadjuvant chemotherapy in breast cancer.
    Cho DH; Bae SY; You JY; Kim HK; Chang YW; Choi YJ; Woo SU; Son GS; Lee JB; Bae JW; Jung SP
    Kaohsiung J Med Sci; 2018 Jun; 34(6):341-347. PubMed ID: 29747778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node ratio as an alternative to pN staging in node-positive breast cancer.
    Vinh-Hung V; Verkooijen HM; Fioretta G; Neyroud-Caspar I; Rapiti E; Vlastos G; Deglise C; Usel M; Lutz JM; Bouchardy C
    J Clin Oncol; 2009 Mar; 27(7):1062-8. PubMed ID: 19164210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node ratio may be supplementary to TNM nodal classification in node-positive breast carcinoma based on the results of 2,151 patients.
    Duraker N; Bati B; Çaynak ZC; Demir D
    World J Surg; 2013 Jun; 37(6):1241-8. PubMed ID: 23456225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in Chinese patients with luminal A breast cancer.
    Wang F; He W; Qiu H; Wang X; Guo G; Chen X; Rong Y; Zhou F; Yin C; Yuan Z; Xia L
    Clin Breast Cancer; 2012 Dec; 12(6):404-11. PubMed ID: 23026023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the axillary lymph node ratio have any added prognostic value over pN staging for South East Asian breast cancer patients?
    Saxena N; Hartman M; Yip CH; Bhoo-Pathy N; Khin LW; Taib NA; Looi LM; Lim SE; Lee SC; Verkooijen HM
    PLoS One; 2012; 7(9):e45809. PubMed ID: 23029254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of residual nodal burden using lymph node ratio in locally advanced breast cancer after neoadjuvant chemotherapy.
    Agarwal R; Philip A; Pavithran K; Rajanbabu A; Goel G; Vijaykumar DK
    Indian J Cancer; 2019; 56(3):228-235. PubMed ID: 31389386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.